Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: A Chinese prospective cohort research developed and validated a risk prediction model for patients with cervical cancer

Fig. 5

The calibration curves used for predicting patient OS at 1-, 3- and 5-years for the training cohort and 1-, 3- and 5-years for the testing cohort. Decision curve analysis evaluated the ability of the nomogram to predict 5-year overall survival in cervical cancer patients in the training (C) and testing (D) cohorts. The nomogram distinguished the risk of cervical cancer patients in the training cohort (E) and the testing cohort (F)

Back to article page